Biogen Slovakia's Country Director on being an innovative global biotech in Slovakia, market access in the country, and the company's commitment to improving the lives of patients through MS, Alzheimer's and rare disease treatments.
Ms. Strapkova Boydova, you have been Country Director of Biogen Slovakia since its inception in 2006. Can you please tell us three to five key milestones in the affiliate’s history since then?
"The market access process is rather straightforward, regulated by official methodology and there is no space for negotiations with authorities."
